Loading…
Loading…
LVVEF (Yooma Wellness Inc) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Toronto, Ontario--(Newsfile Corp. - Le 23 octobre/October 2024) - The common shares of Yooma Wellness Inc. will be delisted from the CSE at market close today, October 23, 2024. Yooma Wellness Inc. is currently suspended.
Toronto, Ontario, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (“Yooma” or the "Company") (CSE: YOOM) (AQSE: YOOM), a global multi-branded wellness platform, including CBD products and other wellness brands, today announces that it has filed an assignment in bankruptcy pursuant to the Bankruptcy and Insolvency Act (Canada). Richter Inc. was appointed as Trustee of the estate.
Toronto, Ontario, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Yooma Wellness Inc . (CSE: YOOM, AQSE: YOOM) ("Yooma" or the "Company") today announced that its wholly-owned subsidiary Yooma Europe Limited (“Yooma Europe”) has completed the sale of Birmingham-based Vitality CBD Limited (“Vitality”), a UK-focused CBD company, for a total consideration of US$2.0 million (the “Disposal”) to Psilobrain Therapeutics Inc. (“Psilobrain”). Psilobrain is a private Canadian biotech company that uses the latest in psychedelic medicine to design products that facilitate evidence-based healing & wellness. Further details regarding Psilobrain is available at www.psilobrain.com.
Yooma Wellness Inc (CSE:YOOM, OTC:LVVEF, AQSE:YOOM) said it is starting to see the early results of its streamlining and rationalisation efforts as it provided a quarterly financial update. Revenues were up 50% year over year at US$3.3mln in the three months ended June 30, while the cost base shrank by 32% to US$2.3mln, resulting in a net loss of around US$1.1mln (down 65% over 12 months).
Yooma Wellness Inc (CSE:YOOM, OTC:LVVEF, AQSE:YOOM) said it is continuing to work with advisors at Canaccord Genuity (TSX:CF, LSE:CF) to assess its strategic options. These may include a sale of assets or further M&A “if financing can be secured on acceptable terms”, said chairman Lorne Abony.
Toronto, Ontario, Canada, May 17, 2022 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. ("Yooma" or the "Company") (CSE: YOOM, AQSE:YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today released its annual financial statements (the "Financial Statements") for the financial year ended December 31, 2021 (the "Reporting Period"). A summary of Yooma's operational and financial highlights during the Reporting Period are set out below and more detailed information is contained in the Financial Statements and related Management Discussion and Analysis, which are available on Yooma's SEDAR page at www.sedar.com.
SEED Innovations Ltd (AIM:SEED, OTC:FFRIF) said it welcomed a UK regulator's list of cannabidiol (CBD) products that can be sold to consumers, which included some of its investee companies. The Investee companies include Yooma Wellness Inc (CSE:YOOM, OTC:LVVEF, AQSE:YOOM) (Yooma Wellness Inc (CSE:YOOM, OTC:LVVEF, AQSE:YOOM), Yooma Wellness Inc (CSE:YOOM, OTC:LVVEF, AQSE:YOOM), Yooma Wellness Inc (CSE:YOOM, OTC:LVVEF, AQSE:YOOM)), South West Brand Limited and CiiTECH Limited.
Yooma Wellness Inc (CSE:YOOM, OTC:LVVEF, AQSE:YOOM) subsidiary Vitality CBD and its product range have been added to the UK Food Standard Agencies (FSA) Novel Foods approved list for cannabidiol (CBD). Only fully compliant products are available for purchase in the UK, said Yooma, and those not on the register will subsequently have to be taken off sale.
No recent filings indexed.